nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—prostate cancer—bone cancer	0.412	1	CtDrD
Estradiol—NR1I2—bone cancer	0.229	0.835	CbGaD
Estradiol—CYP3A4—bone cancer	0.0452	0.165	CbGaD
Estradiol—ABCC10—Doxorubicin—bone cancer	0.0248	0.112	CbGbCtD
Estradiol—ABCC10—Methotrexate—bone cancer	0.024	0.108	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—bone cancer	0.024	0.108	CbGbCtD
Estradiol—AOX1—Methotrexate—bone cancer	0.0227	0.103	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—bone cancer	0.0135	0.0608	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—bone cancer	0.0134	0.0605	CbGbCtD
Estradiol—SLC22A2—Cisplatin—bone cancer	0.013	0.0584	CbGbCtD
Estradiol—SLC22A11—Methotrexate—bone cancer	0.0124	0.0559	CbGbCtD
Estradiol—ABCG2—Carboplatin—bone cancer	0.0112	0.0505	CbGbCtD
Estradiol—ABCG2—Cisplatin—bone cancer	0.00956	0.0431	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—bone cancer	0.00828	0.0373	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—bone cancer	0.00781	0.0352	CbGbCtD
Estradiol—SLC22A8—Methotrexate—bone cancer	0.00721	0.0325	CbGbCtD
Estradiol—ABCG2—Doxorubicin—bone cancer	0.00641	0.0289	CbGbCtD
Estradiol—ABCG2—Methotrexate—bone cancer	0.00621	0.028	CbGbCtD
Estradiol—ALB—Methotrexate—bone cancer	0.00428	0.0193	CbGbCtD
Estradiol—CYP2C9—Cisplatin—bone cancer	0.00355	0.016	CbGbCtD
Estradiol—ABCB1—Cisplatin—bone cancer	0.00345	0.0155	CbGbCtD
Estradiol—ABCB1—Doxorubicin—bone cancer	0.00231	0.0104	CbGbCtD
Estradiol—ABCB1—Methotrexate—bone cancer	0.00224	0.0101	CbGbCtD
Estradiol—CYP3A4—Doxorubicin—bone cancer	0.00138	0.00624	CbGbCtD
Estradiol—Ethinyl Estradiol—NR1I2—bone cancer	0.000449	0.257	CrCbGaD
Estradiol—Estradiol valerate/Dienogest—CYP3A4—bone cancer	0.000365	0.209	CrCbGaD
Estradiol—Fulvestrant—CYP3A4—bone cancer	0.000365	0.209	CrCbGaD
Estradiol—Estramustine—CYP3A4—bone cancer	0.000151	0.0867	CrCbGaD
Estradiol—Estropipate—CYP3A4—bone cancer	0.000125	0.0713	CrCbGaD
Estradiol—Ethinyl Estradiol—CYP3A4—bone cancer	8.89e-05	0.051	CrCbGaD
Estradiol—Conjugated Estrogens—CYP3A4—bone cancer	7.77e-05	0.0445	CrCbGaD
Estradiol—Estrone—CYP3A4—bone cancer	7.75e-05	0.0444	CrCbGaD
Estradiol—Haemoglobin—Methotrexate—bone cancer	4.82e-05	0.000941	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—bone cancer	4.8e-05	0.000936	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—bone cancer	4.8e-05	0.000936	CcSEcCtD
Estradiol—Pollakiuria—Doxorubicin—bone cancer	4.79e-05	0.000936	CcSEcCtD
Estradiol—Haematuria—Epirubicin—bone cancer	4.77e-05	0.000931	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—bone cancer	4.76e-05	0.000929	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—bone cancer	4.74e-05	0.000925	CcSEcCtD
Estradiol—Photosensitivity reaction—Doxorubicin—bone cancer	4.73e-05	0.000925	CcSEcCtD
Estradiol—Hepatobiliary disease—Epirubicin—bone cancer	4.73e-05	0.000923	CcSEcCtD
Estradiol—Weight increased—Doxorubicin—bone cancer	4.72e-05	0.000922	CcSEcCtD
Estradiol—Epistaxis—Epirubicin—bone cancer	4.71e-05	0.000921	CcSEcCtD
Estradiol—Testosterone—CYP3A4—bone cancer	4.71e-05	0.027	CrCbGaD
Estradiol—Urethral disorder—Methotrexate—bone cancer	4.7e-05	0.000918	CcSEcCtD
Estradiol—Weight decreased—Doxorubicin—bone cancer	4.69e-05	0.000916	CcSEcCtD
Estradiol—Sinusitis—Epirubicin—bone cancer	4.69e-05	0.000916	CcSEcCtD
Estradiol—Hyperglycaemia—Doxorubicin—bone cancer	4.68e-05	0.000914	CcSEcCtD
Estradiol—Pneumonia—Doxorubicin—bone cancer	4.65e-05	0.000908	CcSEcCtD
Estradiol—Infestation NOS—Doxorubicin—bone cancer	4.63e-05	0.000903	CcSEcCtD
Estradiol—Infestation—Doxorubicin—bone cancer	4.63e-05	0.000903	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—bone cancer	4.62e-05	0.000902	CcSEcCtD
Estradiol—Hypersensitivity—Cisplatin—bone cancer	4.57e-05	0.000893	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—bone cancer	4.53e-05	0.000885	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—bone cancer	4.53e-05	0.000885	CcSEcCtD
Estradiol—Haemoglobin—Epirubicin—bone cancer	4.51e-05	0.000881	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—bone cancer	4.51e-05	0.00088	CcSEcCtD
Estradiol—Rhinitis—Epirubicin—bone cancer	4.5e-05	0.000878	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—bone cancer	4.5e-05	0.000878	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—bone cancer	4.5e-05	0.000878	CcSEcCtD
Estradiol—Hepatitis—Epirubicin—bone cancer	4.49e-05	0.000876	CcSEcCtD
Estradiol—Haemorrhage—Epirubicin—bone cancer	4.49e-05	0.000876	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—bone cancer	4.48e-05	0.000875	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—bone cancer	4.47e-05	0.000873	CcSEcCtD
Estradiol—Hypoaesthesia—Epirubicin—bone cancer	4.46e-05	0.000872	CcSEcCtD
Estradiol—Asthenia—Cisplatin—bone cancer	4.45e-05	0.00087	CcSEcCtD
Estradiol—Pharyngitis—Epirubicin—bone cancer	4.45e-05	0.00087	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—bone cancer	4.45e-05	0.000869	CcSEcCtD
Estradiol—Urinary tract disorder—Epirubicin—bone cancer	4.43e-05	0.000865	CcSEcCtD
Estradiol—Oedema peripheral—Epirubicin—bone cancer	4.42e-05	0.000863	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—bone cancer	4.41e-05	0.000861	CcSEcCtD
Estradiol—Connective tissue disorder—Epirubicin—bone cancer	4.41e-05	0.000861	CcSEcCtD
Estradiol—Urethral disorder—Epirubicin—bone cancer	4.4e-05	0.000859	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—bone cancer	4.37e-05	0.000854	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—bone cancer	4.36e-05	0.000852	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—bone cancer	4.35e-05	0.000849	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—bone cancer	4.34e-05	0.000847	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—bone cancer	4.33e-05	0.000846	CcSEcCtD
Estradiol—Visual impairment—Epirubicin—bone cancer	4.32e-05	0.000844	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—bone cancer	4.32e-05	0.000844	CcSEcCtD
Estradiol—Chills—Methotrexate—bone cancer	4.3e-05	0.00084	CcSEcCtD
Estradiol—Diarrhoea—Cisplatin—bone cancer	4.25e-05	0.000829	CcSEcCtD
Estradiol—Erythema multiforme—Epirubicin—bone cancer	4.24e-05	0.000828	CcSEcCtD
Estradiol—Alopecia—Methotrexate—bone cancer	4.24e-05	0.000827	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—bone cancer	4.2e-05	0.00082	CcSEcCtD
Estradiol—Eye disorder—Epirubicin—bone cancer	4.19e-05	0.000819	CcSEcCtD
Estradiol—Tinnitus—Epirubicin—bone cancer	4.18e-05	0.000817	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—bone cancer	4.17e-05	0.000815	CcSEcCtD
Estradiol—Erythema—Methotrexate—bone cancer	4.17e-05	0.000815	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—bone cancer	4.17e-05	0.000815	CcSEcCtD
Estradiol—Flushing—Epirubicin—bone cancer	4.16e-05	0.000813	CcSEcCtD
Estradiol—Cardiac disorder—Epirubicin—bone cancer	4.16e-05	0.000813	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—bone cancer	4.16e-05	0.000813	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—bone cancer	4.15e-05	0.000811	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—bone cancer	4.15e-05	0.000811	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—bone cancer	4.13e-05	0.000807	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—bone cancer	4.12e-05	0.000805	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—bone cancer	4.1e-05	0.000801	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—bone cancer	4.09e-05	0.000799	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—bone cancer	4.09e-05	0.000798	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—bone cancer	4.08e-05	0.000797	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—bone cancer	4.07e-05	0.000795	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—bone cancer	4.07e-05	0.000795	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—bone cancer	4.05e-05	0.000791	CcSEcCtD
Estradiol—Mediastinal disorder—Epirubicin—bone cancer	4.04e-05	0.00079	CcSEcCtD
Estradiol—Back pain—Methotrexate—bone cancer	4.04e-05	0.000788	CcSEcCtD
Estradiol—Chills—Epirubicin—bone cancer	4.03e-05	0.000786	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—bone cancer	4e-05	0.000781	CcSEcCtD
Estradiol—Alopecia—Epirubicin—bone cancer	3.97e-05	0.000774	CcSEcCtD
Estradiol—Vomiting—Cisplatin—bone cancer	3.95e-05	0.000771	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—bone cancer	3.93e-05	0.000768	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—bone cancer	3.93e-05	0.000767	CcSEcCtD
Estradiol—Rash—Cisplatin—bone cancer	3.91e-05	0.000764	CcSEcCtD
Estradiol—Dermatitis—Cisplatin—bone cancer	3.91e-05	0.000764	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—bone cancer	3.91e-05	0.000763	CcSEcCtD
Estradiol—Erythema—Epirubicin—bone cancer	3.91e-05	0.000763	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—bone cancer	3.88e-05	0.000758	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—bone cancer	3.87e-05	0.000756	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—bone cancer	3.87e-05	0.000756	CcSEcCtD
Estradiol—Flushing—Doxorubicin—bone cancer	3.85e-05	0.000752	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—bone cancer	3.85e-05	0.000752	CcSEcCtD
Estradiol—Flatulence—Epirubicin—bone cancer	3.85e-05	0.000752	CcSEcCtD
Estradiol—Tension—Epirubicin—bone cancer	3.83e-05	0.000748	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—bone cancer	3.83e-05	0.000747	CcSEcCtD
Estradiol—Nervousness—Epirubicin—bone cancer	3.79e-05	0.000741	CcSEcCtD
Estradiol—Back pain—Epirubicin—bone cancer	3.78e-05	0.000738	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—bone cancer	3.77e-05	0.000736	CcSEcCtD
Estradiol—Malaise—Methotrexate—bone cancer	3.76e-05	0.000735	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—bone cancer	3.76e-05	0.000733	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—bone cancer	3.75e-05	0.000732	CcSEcCtD
Estradiol—Vertigo—Methotrexate—bone cancer	3.75e-05	0.000732	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—bone cancer	3.74e-05	0.000731	CcSEcCtD
Estradiol—Chills—Doxorubicin—bone cancer	3.73e-05	0.000727	CcSEcCtD
Estradiol—Nausea—Cisplatin—bone cancer	3.69e-05	0.00072	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—bone cancer	3.67e-05	0.000716	CcSEcCtD
Estradiol—Cough—Methotrexate—bone cancer	3.64e-05	0.000711	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—bone cancer	3.64e-05	0.00071	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—bone cancer	3.62e-05	0.000708	CcSEcCtD
Estradiol—Erythema—Doxorubicin—bone cancer	3.61e-05	0.000706	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—bone cancer	3.61e-05	0.000706	CcSEcCtD
Estradiol—Agitation—Epirubicin—bone cancer	3.59e-05	0.000701	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—bone cancer	3.56e-05	0.000695	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—bone cancer	3.55e-05	0.000694	CcSEcCtD
Estradiol—Myalgia—Methotrexate—bone cancer	3.55e-05	0.000694	CcSEcCtD
Estradiol—Chest pain—Methotrexate—bone cancer	3.55e-05	0.000694	CcSEcCtD
Estradiol—Tension—Doxorubicin—bone cancer	3.55e-05	0.000693	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—bone cancer	3.54e-05	0.000691	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	3.53e-05	0.000689	CcSEcCtD
Estradiol—Malaise—Epirubicin—bone cancer	3.52e-05	0.000688	CcSEcCtD
Estradiol—Discomfort—Methotrexate—bone cancer	3.51e-05	0.000686	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—bone cancer	3.51e-05	0.000685	CcSEcCtD
Estradiol—Vertigo—Epirubicin—bone cancer	3.51e-05	0.000685	CcSEcCtD
Estradiol—Syncope—Epirubicin—bone cancer	3.5e-05	0.000684	CcSEcCtD
Estradiol—Back pain—Doxorubicin—bone cancer	3.5e-05	0.000683	CcSEcCtD
Estradiol—Muscle spasms—Doxorubicin—bone cancer	3.48e-05	0.000679	CcSEcCtD
Estradiol—Palpitations—Epirubicin—bone cancer	3.45e-05	0.000674	CcSEcCtD
Estradiol—Confusional state—Methotrexate—bone cancer	3.43e-05	0.000671	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—bone cancer	3.43e-05	0.00067	CcSEcCtD
Estradiol—Cough—Epirubicin—bone cancer	3.41e-05	0.000666	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—bone cancer	3.41e-05	0.000665	CcSEcCtD
Estradiol—Infection—Methotrexate—bone cancer	3.38e-05	0.000661	CcSEcCtD
Estradiol—Hypertension—Epirubicin—bone cancer	3.37e-05	0.000659	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—bone cancer	3.35e-05	0.000655	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—bone cancer	3.34e-05	0.000652	CcSEcCtD
Estradiol—Myalgia—Epirubicin—bone cancer	3.33e-05	0.000649	CcSEcCtD
Estradiol—Chest pain—Epirubicin—bone cancer	3.33e-05	0.000649	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—bone cancer	3.33e-05	0.000649	CcSEcCtD
Estradiol—Agitation—Doxorubicin—bone cancer	3.32e-05	0.000649	CcSEcCtD
Estradiol—Anxiety—Epirubicin—bone cancer	3.31e-05	0.000647	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—bone cancer	3.31e-05	0.000646	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	3.3e-05	0.000645	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—bone cancer	3.29e-05	0.000643	CcSEcCtD
Estradiol—Discomfort—Epirubicin—bone cancer	3.29e-05	0.000642	CcSEcCtD
Estradiol—Malaise—Doxorubicin—bone cancer	3.26e-05	0.000636	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—bone cancer	3.25e-05	0.000635	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—bone cancer	3.25e-05	0.000634	CcSEcCtD
Estradiol—Syncope—Doxorubicin—bone cancer	3.24e-05	0.000633	CcSEcCtD
Estradiol—Confusional state—Epirubicin—bone cancer	3.21e-05	0.000628	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—bone cancer	3.19e-05	0.000624	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—bone cancer	3.19e-05	0.000622	CcSEcCtD
Estradiol—Oedema—Epirubicin—bone cancer	3.19e-05	0.000622	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—bone cancer	3.18e-05	0.00062	CcSEcCtD
Estradiol—Infection—Epirubicin—bone cancer	3.17e-05	0.000618	CcSEcCtD
Estradiol—Cough—Doxorubicin—bone cancer	3.15e-05	0.000616	CcSEcCtD
Estradiol—Shock—Epirubicin—bone cancer	3.14e-05	0.000612	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—bone cancer	3.13e-05	0.00061	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—bone cancer	3.12e-05	0.000609	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—bone cancer	3.11e-05	0.000608	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—bone cancer	3.1e-05	0.000606	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—bone cancer	3.1e-05	0.000605	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—bone cancer	3.08e-05	0.000602	CcSEcCtD
Estradiol—Insomnia—Methotrexate—bone cancer	3.08e-05	0.000602	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—bone cancer	3.08e-05	0.000601	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—bone cancer	3.08e-05	0.000601	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—bone cancer	3.08e-05	0.000601	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—bone cancer	3.07e-05	0.000599	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—bone cancer	3.06e-05	0.000597	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	3.06e-05	0.000597	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—bone cancer	3.04e-05	0.000594	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—bone cancer	3.04e-05	0.000593	CcSEcCtD
Estradiol—Somnolence—Methotrexate—bone cancer	3.03e-05	0.000591	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—bone cancer	3.01e-05	0.000588	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—bone cancer	3e-05	0.000586	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—bone cancer	2.97e-05	0.000581	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—bone cancer	2.96e-05	0.000578	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—bone cancer	2.95e-05	0.000576	CcSEcCtD
Estradiol—Oedema—Doxorubicin—bone cancer	2.95e-05	0.000576	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—bone cancer	2.94e-05	0.000574	CcSEcCtD
Estradiol—Fatigue—Methotrexate—bone cancer	2.94e-05	0.000573	CcSEcCtD
Estradiol—Infection—Doxorubicin—bone cancer	2.93e-05	0.000572	CcSEcCtD
Estradiol—Pain—Methotrexate—bone cancer	2.91e-05	0.000569	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—bone cancer	2.9e-05	0.000567	CcSEcCtD
Estradiol—Shock—Doxorubicin—bone cancer	2.9e-05	0.000567	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—bone cancer	2.89e-05	0.000565	CcSEcCtD
Estradiol—Insomnia—Epirubicin—bone cancer	2.88e-05	0.000563	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—bone cancer	2.88e-05	0.000562	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—bone cancer	2.87e-05	0.000559	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—bone cancer	2.86e-05	0.000559	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—bone cancer	2.85e-05	0.000557	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—bone cancer	2.84e-05	0.000555	CcSEcCtD
Estradiol—Somnolence—Epirubicin—bone cancer	2.83e-05	0.000553	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—bone cancer	2.81e-05	0.000548	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—bone cancer	2.81e-05	0.000548	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—bone cancer	2.79e-05	0.000544	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—bone cancer	2.77e-05	0.000541	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—bone cancer	2.75e-05	0.000537	CcSEcCtD
Estradiol—Fatigue—Epirubicin—bone cancer	2.75e-05	0.000537	CcSEcCtD
Estradiol—Pain—Epirubicin—bone cancer	2.73e-05	0.000532	CcSEcCtD
Estradiol—Constipation—Epirubicin—bone cancer	2.73e-05	0.000532	CcSEcCtD
Estradiol—Urticaria—Methotrexate—bone cancer	2.71e-05	0.000528	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—bone cancer	2.69e-05	0.000526	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—bone cancer	2.69e-05	0.000526	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—bone cancer	2.69e-05	0.000525	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—bone cancer	2.67e-05	0.000521	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—bone cancer	2.65e-05	0.000517	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—bone cancer	2.63e-05	0.000514	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—bone cancer	2.63e-05	0.000513	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—bone cancer	2.62e-05	0.000512	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—bone cancer	2.61e-05	0.000509	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—bone cancer	2.6e-05	0.000507	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—bone cancer	2.56e-05	0.000501	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—bone cancer	2.55e-05	0.000497	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—bone cancer	2.54e-05	0.000497	CcSEcCtD
Estradiol—Urticaria—Epirubicin—bone cancer	2.53e-05	0.000495	CcSEcCtD
Estradiol—Constipation—Doxorubicin—bone cancer	2.52e-05	0.000493	CcSEcCtD
Estradiol—Pain—Doxorubicin—bone cancer	2.52e-05	0.000493	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—bone cancer	2.52e-05	0.000492	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—bone cancer	2.52e-05	0.000492	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—bone cancer	2.51e-05	0.00049	CcSEcCtD
Estradiol—Asthenia—Methotrexate—bone cancer	2.44e-05	0.000477	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—bone cancer	2.43e-05	0.000475	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—bone cancer	2.41e-05	0.000471	CcSEcCtD
Estradiol—Pruritus—Methotrexate—bone cancer	2.41e-05	0.000471	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—bone cancer	2.35e-05	0.000459	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—bone cancer	2.34e-05	0.000458	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—bone cancer	2.33e-05	0.000455	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—bone cancer	2.33e-05	0.000455	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—bone cancer	2.33e-05	0.000455	CcSEcCtD
Estradiol—Asthenia—Epirubicin—bone cancer	2.29e-05	0.000447	CcSEcCtD
Estradiol—Pruritus—Epirubicin—bone cancer	2.26e-05	0.00044	CcSEcCtD
Estradiol—Dizziness—Methotrexate—bone cancer	2.25e-05	0.00044	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—bone cancer	2.18e-05	0.000426	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—bone cancer	2.17e-05	0.000424	CcSEcCtD
Estradiol—Vomiting—Methotrexate—bone cancer	2.17e-05	0.000423	CcSEcCtD
Estradiol—Rash—Methotrexate—bone cancer	2.15e-05	0.000419	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—bone cancer	2.15e-05	0.000419	CcSEcCtD
Estradiol—Headache—Methotrexate—bone cancer	2.13e-05	0.000417	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—bone cancer	2.12e-05	0.000413	CcSEcCtD
Estradiol—Dizziness—Epirubicin—bone cancer	2.11e-05	0.000412	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—bone cancer	2.09e-05	0.000408	CcSEcCtD
Estradiol—Vomiting—Epirubicin—bone cancer	2.03e-05	0.000396	CcSEcCtD
Estradiol—Nausea—Methotrexate—bone cancer	2.02e-05	0.000395	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—bone cancer	2.02e-05	0.000394	CcSEcCtD
Estradiol—Rash—Epirubicin—bone cancer	2.01e-05	0.000392	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—bone cancer	2.01e-05	0.000392	CcSEcCtD
Estradiol—Headache—Epirubicin—bone cancer	2e-05	0.00039	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—bone cancer	1.95e-05	0.000381	CcSEcCtD
Estradiol—Nausea—Epirubicin—bone cancer	1.89e-05	0.00037	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—bone cancer	1.88e-05	0.000366	CcSEcCtD
Estradiol—Rash—Doxorubicin—bone cancer	1.86e-05	0.000363	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—bone cancer	1.86e-05	0.000363	CcSEcCtD
Estradiol—Headache—Doxorubicin—bone cancer	1.85e-05	0.000361	CcSEcCtD
Estradiol—Nausea—Doxorubicin—bone cancer	1.75e-05	0.000342	CcSEcCtD
Estradiol—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	1.58e-05	0.0004	CbGpPWpGaD
Estradiol—AR—Gene Expression—NR1I2—bone cancer	1.56e-05	0.000395	CbGpPWpGaD
Estradiol—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	1.56e-05	0.000394	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.56e-05	0.000394	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—NT5C3A—bone cancer	1.56e-05	0.000393	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.55e-05	0.000392	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—NT5C3A—bone cancer	1.54e-05	0.00039	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—KIT—bone cancer	1.54e-05	0.00039	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—NT5C3A—bone cancer	1.54e-05	0.000389	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.54e-05	0.000389	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.54e-05	0.000388	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—EZH2—bone cancer	1.53e-05	0.000387	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.53e-05	0.000386	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	1.51e-05	0.000381	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ENO2—bone cancer	1.5e-05	0.00038	CbGpPWpGaD
Estradiol—CYP2C19—Biological oxidations—GSTP1—bone cancer	1.48e-05	0.000375	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.48e-05	0.000375	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	1.46e-05	0.00037	CbGpPWpGaD
Estradiol—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	1.46e-05	0.00037	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—GSTP1—bone cancer	1.46e-05	0.000369	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.46e-05	0.000368	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—BRAF—bone cancer	1.45e-05	0.000366	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.45e-05	0.000366	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—NT5C3A—bone cancer	1.43e-05	0.000363	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.42e-05	0.000359	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	1.4e-05	0.000355	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—EGFR—bone cancer	1.4e-05	0.000355	CbGpPWpGaD
Estradiol—AOX1—Metabolism—DHFR—bone cancer	1.4e-05	0.000353	CbGpPWpGaD
Estradiol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.38e-05	0.000348	CbGpPWpGaD
Estradiol—CYP2C9—Biological oxidations—GSTP1—bone cancer	1.35e-05	0.000342	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.35e-05	0.000342	CbGpPWpGaD
Estradiol—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.35e-05	0.000342	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NDUFA12—bone cancer	1.34e-05	0.00034	CbGpPWpGaD
Estradiol—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	1.33e-05	0.000337	CbGpPWpGaD
Estradiol—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.33e-05	0.000337	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.3e-05	0.00033	CbGpPWpGaD
Estradiol—AOX1—Metabolism—GNA11—bone cancer	1.3e-05	0.00033	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.3e-05	0.000329	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.3e-05	0.000328	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.28e-05	0.000323	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NDUFA12—bone cancer	1.27e-05	0.000321	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	1.26e-05	0.000319	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.22e-05	0.000308	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.22e-05	0.000308	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	1.22e-05	0.000307	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MDM2—bone cancer	1.21e-05	0.000307	CbGpPWpGaD
Estradiol—AOX1—Disease—TGFBR2—bone cancer	1.21e-05	0.000305	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—NR1I2—bone cancer	1.2e-05	0.000305	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.2e-05	0.000303	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CYP3A4—bone cancer	1.18e-05	0.000299	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	1.18e-05	0.000297	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.18e-05	0.000297	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NDUFA12—bone cancer	1.16e-05	0.000294	CbGpPWpGaD
Estradiol—ALB—Metabolism—NDUFA12—bone cancer	1.16e-05	0.000293	CbGpPWpGaD
Estradiol—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.16e-05	0.000292	CbGpPWpGaD
Estradiol—AR—Gene Expression—EIF2S1—bone cancer	1.16e-05	0.000292	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—BRAF—bone cancer	1.15e-05	0.000292	CbGpPWpGaD
Estradiol—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.14e-05	0.000288	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.12e-05	0.000283	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.12e-05	0.000282	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NT5C3A—bone cancer	1.11e-05	0.000282	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—EGFR—bone cancer	1.11e-05	0.00028	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TP53—bone cancer	1.1e-05	0.000277	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ENO2—bone cancer	1.1e-05	0.000277	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—BRAF—bone cancer	1.08e-05	0.000272	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ENO2—bone cancer	1.08e-05	0.000272	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—JUN—bone cancer	1.06e-05	0.000267	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NT5C3A—bone cancer	1.05e-05	0.000266	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NDUFA12—bone cancer	1.04e-05	0.000263	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MMP9—bone cancer	1.03e-05	0.000259	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—DHFR—bone cancer	1.02e-05	0.000257	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NDUFA12—bone cancer	1.01e-05	0.000257	CbGpPWpGaD
Estradiol—AOX1—Metabolism—GSTP1—bone cancer	1.01e-05	0.000256	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.01e-05	0.000255	CbGpPWpGaD
Estradiol—AR—Gene Expression—EZH2—bone cancer	1e-05	0.000254	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—DHFR—bone cancer	9.97e-06	0.000252	CbGpPWpGaD
Estradiol—ALB—Hemostasis—SPARC—bone cancer	9.83e-06	0.000248	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—MDM2—bone cancer	9.67e-06	0.000245	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	9.65e-06	0.000244	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NT5C3A—bone cancer	9.65e-06	0.000244	CbGpPWpGaD
Estradiol—ALB—Metabolism—NT5C3A—bone cancer	9.6e-06	0.000243	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—GNA11—bone cancer	9.5e-06	0.00024	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NDUFA12—bone cancer	9.48e-06	0.00024	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	9.37e-06	0.000237	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—GNA11—bone cancer	9.32e-06	0.000236	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	9.24e-06	0.000234	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GRM4—bone cancer	9.03e-06	0.000228	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RGS1—bone cancer	9.03e-06	0.000228	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—MDM2—bone cancer	9.02e-06	0.000228	CbGpPWpGaD
Estradiol—ALB—Hemostasis—GNA11—bone cancer	8.99e-06	0.000227	CbGpPWpGaD
Estradiol—CYP3A4—Biological oxidations—GSTP1—bone cancer	8.92e-06	0.000226	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—EIF2S1—bone cancer	8.9e-06	0.000225	CbGpPWpGaD
Estradiol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.8e-06	0.000222	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NT5C3A—bone cancer	8.62e-06	0.000218	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CYP3A4—bone cancer	8.61e-06	0.000218	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ENO2—bone cancer	8.6e-06	0.000218	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.57e-06	0.000217	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CYP3A4—bone cancer	8.45e-06	0.000214	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NT5C3A—bone cancer	8.41e-06	0.000213	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—EGFR—bone cancer	8.29e-06	0.00021	CbGpPWpGaD
Estradiol—AOX1—Disease—KIT—bone cancer	8.24e-06	0.000208	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL3—bone cancer	8.15e-06	0.000206	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NDUFA12—bone cancer	8.1e-06	0.000205	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ENO2—bone cancer	8.03e-06	0.000203	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—DHFR—bone cancer	7.98e-06	0.000202	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NT5C3A—bone cancer	7.86e-06	0.000199	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GRM1—bone cancer	7.83e-06	0.000198	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	7.76e-06	0.000196	CbGpPWpGaD
Estradiol—AOX1—Disease—BRAF—bone cancer	7.74e-06	0.000196	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—EZH2—bone cancer	7.73e-06	0.000195	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PTGS2—bone cancer	7.56e-06	0.000191	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ENO2—bone cancer	7.49e-06	0.000189	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—GNA11—bone cancer	7.46e-06	0.000189	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—DHFR—bone cancer	7.45e-06	0.000188	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—GSTP1—bone cancer	7.36e-06	0.000186	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ENO2—bone cancer	7.36e-06	0.000186	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—GSTP1—bone cancer	7.23e-06	0.000183	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.16e-06	0.000181	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TP53—bone cancer	6.96e-06	0.000176	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—GNA11—bone cancer	6.96e-06	0.000176	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—DHFR—bone cancer	6.95e-06	0.000176	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.9e-06	0.000174	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—DHFR—bone cancer	6.83e-06	0.000173	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ENO2—bone cancer	6.81e-06	0.000172	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CYP3A4—bone cancer	6.76e-06	0.000171	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ENO2—bone cancer	6.75e-06	0.000171	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ENO2—bone cancer	6.74e-06	0.00017	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.73e-06	0.00017	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NT5C3A—bone cancer	6.71e-06	0.00017	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—GNA11—bone cancer	6.49e-06	0.000164	CbGpPWpGaD
Estradiol—AOX1—Disease—MDM2—bone cancer	6.49e-06	0.000164	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—GNA11—bone cancer	6.38e-06	0.000161	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—DHFR—bone cancer	6.32e-06	0.00016	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CYP3A4—bone cancer	6.31e-06	0.00016	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ENO2—bone cancer	6.28e-06	0.000159	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—DHFR—bone cancer	6.27e-06	0.000158	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—DHFR—bone cancer	6.26e-06	0.000158	CbGpPWpGaD
Estradiol—AOX1—Disease—PTGS2—bone cancer	6.25e-06	0.000158	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NDUFA12—bone cancer	6.25e-06	0.000158	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.22e-06	0.000157	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—GNA11—bone cancer	5.91e-06	0.000149	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CYP3A4—bone cancer	5.89e-06	0.000149	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.86e-06	0.000148	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—GNA11—bone cancer	5.86e-06	0.000148	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—GNA11—bone cancer	5.85e-06	0.000148	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—DHFR—bone cancer	5.83e-06	0.000147	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—GSTP1—bone cancer	5.78e-06	0.000146	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CYP3A4—bone cancer	5.78e-06	0.000146	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.75e-06	0.000145	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SMO—bone cancer	5.52e-06	0.00014	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GNA11—bone cancer	5.45e-06	0.000138	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—GSTP1—bone cancer	5.4e-06	0.000136	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CYP3A4—bone cancer	5.36e-06	0.000135	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PLAU—bone cancer	5.35e-06	0.000135	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CYP3A4—bone cancer	5.31e-06	0.000134	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CYP3A4—bone cancer	5.3e-06	0.000134	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTGS2—bone cancer	5.24e-06	0.000132	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NT5C3A—bone cancer	5.18e-06	0.000131	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GNA11—bone cancer	5.05e-06	0.000128	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—GSTP1—bone cancer	5.03e-06	0.000127	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—GSTP1—bone cancer	4.95e-06	0.000125	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CYP3A4—bone cancer	4.94e-06	0.000125	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.89e-06	0.000124	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ENO2—bone cancer	4.88e-06	0.000123	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ATF1—bone cancer	4.69e-06	0.000119	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ENO2—bone cancer	4.61e-06	0.000117	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—GSTP1—bone cancer	4.58e-06	0.000116	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL3—bone cancer	4.58e-06	0.000116	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—GSTP1—bone cancer	4.54e-06	0.000115	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—GSTP1—bone cancer	4.53e-06	0.000115	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—DHFR—bone cancer	4.53e-06	0.000114	CbGpPWpGaD
Estradiol—AOX1—Disease—EGFR—bone cancer	4.43e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—DHFR—bone cancer	4.28e-06	0.000108	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GNA11—bone cancer	4.23e-06	0.000107	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ENO2—bone cancer	4.23e-06	0.000107	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GSTP1—bone cancer	4.23e-06	0.000107	CbGpPWpGaD
Estradiol—ALB—Metabolism—ENO2—bone cancer	4.2e-06	0.000106	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.11e-06	0.000104	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GNA11—bone cancer	4e-06	0.000101	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—DHFR—bone cancer	3.92e-06	9.92e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFBR2—bone cancer	3.91e-06	9.89e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—DHFR—bone cancer	3.9e-06	9.86e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP3A4—bone cancer	3.84e-06	9.7e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—bone cancer	3.81e-06	9.64e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ENO2—bone cancer	3.77e-06	9.54e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—bone cancer	3.74e-06	9.47e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ENO2—bone cancer	3.68e-06	9.31e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IGF1R—bone cancer	3.68e-06	9.31e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GNA11—bone cancer	3.67e-06	9.27e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GNA11—bone cancer	3.65e-06	9.21e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP3A4—bone cancer	3.63e-06	9.16e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.61e-06	9.12e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—DHFR—bone cancer	3.5e-06	8.85e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ENO2—bone cancer	3.44e-06	8.7e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—DHFR—bone cancer	3.42e-06	8.64e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP3A4—bone cancer	3.32e-06	8.4e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.31e-06	8.36e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP3A4—bone cancer	3.3e-06	8.35e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.29e-06	8.31e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTP1—bone cancer	3.28e-06	8.3e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GNA11—bone cancer	3.27e-06	8.27e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GNA11—bone cancer	3.19e-06	8.07e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—DHFR—bone cancer	3.19e-06	8.07e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTP1—bone cancer	3.1e-06	7.84e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—bone cancer	3e-06	7.58e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GNA11—bone cancer	2.98e-06	7.54e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP3A4—bone cancer	2.97e-06	7.5e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.95e-06	7.46e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ENO2—bone cancer	2.94e-06	7.43e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP3A4—bone cancer	2.9e-06	7.32e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTP1—bone cancer	2.84e-06	7.19e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTP1—bone cancer	2.83e-06	7.14e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—bone cancer	2.8e-06	7.07e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—DHFR—bone cancer	2.73e-06	6.9e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP3A4—bone cancer	2.71e-06	6.84e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.69e-06	6.8e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KIT—bone cancer	2.67e-06	6.75e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—bone cancer	2.61e-06	6.59e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—bone cancer	2.56e-06	6.48e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GNA11—bone cancer	2.55e-06	6.45e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTP1—bone cancer	2.54e-06	6.41e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BRAF—bone cancer	2.51e-06	6.35e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTP1—bone cancer	2.48e-06	6.26e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—bone cancer	2.37e-06	6e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—bone cancer	2.35e-06	5.95e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—bone cancer	2.35e-06	5.94e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—bone cancer	2.31e-06	5.85e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP3A4—bone cancer	2.31e-06	5.84e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.3e-06	5.81e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO2—bone cancer	2.27e-06	5.74e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—bone cancer	2.19e-06	5.53e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—bone cancer	2.15e-06	5.43e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—DHFR—bone cancer	2.11e-06	5.32e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MDM2—bone cancer	2.1e-06	5.32e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—bone cancer	1.98e-06	5e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GNA11—bone cancer	1.97e-06	4.97e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—JUN—bone cancer	1.83e-06	4.62e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—bone cancer	1.78e-06	4.5e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—bone cancer	1.7e-06	4.3e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—bone cancer	1.61e-06	4.06e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—bone cancer	1.53e-06	3.86e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—bone cancer	1.47e-06	3.72e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—bone cancer	1.46e-06	3.7e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—bone cancer	1.44e-06	3.63e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—bone cancer	1.31e-06	3.32e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—bone cancer	1.28e-06	3.24e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—bone cancer	1.21e-06	3.05e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—bone cancer	1.2e-06	3.03e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—bone cancer	1.02e-06	2.59e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—bone cancer	7.9e-07	2e-05	CbGpPWpGaD
